• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Medical Marijuana I (OP: MJNA )

    0.0016 -0.0002 (-11.11%)
    Streaming Delayed Price Updated: 1:27 PM EDT, Jun 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,806,183
    Open 0.0018
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0018
    Today's Range 0.0016 - 0.0018
    52wk Range 0.0001 - 0.0075
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Cannabis
    Exposures Cannabis
    Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research
    SAN DIEGO, CA - (NewMediaWire) - June 26, 2024 - Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that Kannalife Sciences, Inc. (Kannalife"), a wholly-owned subsidiary of the... 
    Via TheNewswire.com
    Topics Cannabis
    Exposures Cannabis

    Performance

    YTD
    -54.29%
    -54.29%
    1 Month
    -20.00%
    -20.00%
    3 Month
    -40.74%
    -40.74%
    6 Month
    -57.89%
    -57.89%
    1 Year
    -51.52%
    -51.52%

    More News

    Read More
    Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    NY Supreme Court's Landmark Ruling Upholds Medical Marijuana Patient's Rights Under Human Rights Law
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
    From Medical Marijuana, Inc.
    Via Business Wire
    Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
    Via Benzinga
    Key Marijuana Executive Changes You Should Know About, New Appointments & More
    Via Benzinga
    Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
    Via NewMediaWire
    Topics Cannabis
    Exposures Cannabis
    CBD For Traumatic Brain Injuries? Oral Administration Reduces Levels Of Neuronal Death In Animal Model, New Study
    Via Benzinga
    Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Medical Marijuana Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
    Via Benzinga
    Medical Marijuana, Inc. Subsidiary HempMeds Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
    Via NewMediaWire
    Topics Cannabis Economy Lawsuit
    Exposures Cannabis Financial Legal
    Key Cannabis Exec Changes You Need To Know About: Dutchie Taps New CEO, Illinois' New Cannabis Officer & More
    Via Benzinga
    Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Medical Marijuana Q3 Revenue Declines 37% Sequentially, Here Are The Details
    Via Benzinga
    Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Argentina's 'Cannabis Conicet' Public Company Seeks To Strengthen The Industry In South America
    Via Benzinga
    Medical Marijuana, Inc. Subsidiary HempMeds Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Medical Marijuana, Inc. Subsidiary HempMeds Mexico Undertakes Promising CBD Research For Parkinson's Treatment
    Via Benzinga
    Medical Marijuana, Inc. Subsidiary HempMeds Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
    Via NewMediaWire
    Topics Cannabis Economy
    Exposures Cannabis Supply Chain
    Cannabis companies are thriving as a result of Europe’s call for medical marijuana
    Via PressReach
    Topics Cannabis Derivatives
    Exposures Cannabis Derivatives
    Medical Marijuana Signs Distribution Agreement With Complete Hemp Technologies
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.